Evidence map›Paper›PMID 37313135›Full record

ReviewHeliyon2023

Progress in traditional Chinese medicine against chronic gastritis: From chronic non-atrophic gastritis to gastric precancerous lesions.

Liangjun Yang, Xinying Liu, Jiajie Zhu, Xi Zhang, Ya Li, Jiabing Chen, Haiyan Liu

Abstract readReview
In one paragraph

Review in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Current pharmaceutical design · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Influence ofHeliyon · 2024
    Article
  17. Article
  18. The effects and mechanisms of natural products onFrontiers in cellular and infection microbiology · 2024
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Liangjun YangTongde Hospital of Zhejiang Province, Hangzhou 310012, China.
Xinying LiuTongde Hospital of Zhejiang Province, Hangzhou 310012, China.
Jiajie ZhuTongde Hospital of Zhejiang Province, Hangzhou 310012, China.
Xi ZhangGuangzhou University of Chinese Medicine, Guangzhou 510405, China.
Ya LiLin 'an Hospital of Traditional Chinese Medicine, Hangzhou 311300, China.
Jiabing ChenTongde Hospital of Zhejiang Province, Hangzhou 310012, China.
Haiyan LiuTongde Hospital of Zhejiang Province, Hangzhou 310012, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic gastritis (CG) is a persistent inflammation of the gastric mucosa that can cause uncomfortable symptoms in patients. Traditional Chinese medicine (TCM) has been widely used to treat CG due to its precise efficacy, minimal side effects, and holistic approach. Clinical studies have confirmed the effectiveness of TCM in treating CG, although the mechanisms underlying this treatment have not yet been fully elucidated. In this review, we summarized the clinical research and mechanisms of TCM used to treat CG. Studies have shown that TCM mechanisms for CG treatment include

Indexed as

Atrophic gastritisChronic gastritis (CG)MechanismTraditional Chinese medicine (TCM)

Identifiers

PMID37313135
PMCPMC10258419

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.